Form 4: Rocket Pharmaceuticals CEO Sells Shares for Tax Withholding

Rocket Pharmaceuticals CEO Gaurav Shah sold 2,728 shares of common stock for $3.60 per share to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• Gaurav Shah, CEO of Rocket Pharmaceuticals, reported a transaction on May 13, 2026.
• He sold 2,728 shares of common stock at a price of $3.60 per share.
• The sale was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Shah directly beneficially owns 1,043,327 shares.
• Additionally, he indirectly beneficially owns 207,897 shares through his spouse and 198,341 shares through the Gaurav D. Shah Irrevocable Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was for tax withholding purposes related to RSU vesting, a standard procedure for executives.

Negatives

• CEO sold a portion of his holdings, although for tax purposes.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding are common events, particularly with the vesting of RSUs, and do not necessarily indicate a negative view of the company's prospects.

Stakeholder Impact

• Shareholders: The sale is a routine transaction for tax purposes and does not inherently signal a change in the CEO's confidence in the company.

Key Dates

Keywords

Rocket Pharmaceuticals, RCKT, Form 4, Insider Transaction, Stock Sale, CEO, Restricted Stock Units, Tax Withholding